Arbutus Biopharma
ABUS
ABUS
144 hedge funds and large institutions have $389M invested in Arbutus Biopharma in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 11 closing their positions.
Holders
144
Holders Change
+14
Holders Change %
+10.77%
% of All Funds
2.08%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
28
Increased
47
Reduced
32
Closed
11
Calls
$9.3M
Puts
$2.17M
Net Calls
+$7.13M
Net Calls Change
-$2.63M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$34.3M |
2 |
2
State Street
Boston,
Massachusetts
|
$17M |
3 |
3
Charles Schwab
San Francisco,
California
|
$4.67M |
4 |
4
Morgan Stanley
New York
|
$83.6M |
5 |
5
BlackRock
New York
|
$47M |